Cell therapy against cerebral stroke : comprehensive reviews for translational researches and clinical trials /: comprehensive reviews for translational researches and clinical trials. (2017)

• Record Type: Book
• Further Information: Note: Kiyohiro Houkin, Koji Abe, Satoshi Kuroda, editors.
• Editors: Houkin, Kiyohiro; Abe, Kōji; Kuroda, Satoshi
• Contents: Part I. Optimal Cell Sources -- 1. Bone Marrow-Derived Mononuclear Cells -- 2. Mesenchymal Stem Cells / Bone Marrow Stromal Cells -- 3. Neural Stem Cells / Neuronal Progenitor Cells -- 4. iPS Cells / iN -- Part II. Translational Research -- 5. Cell Culture -- 6. Cell Dose, Timing and Route -- 7. Scaffold -- 8. Cell Tracking -- 9. Functional Bio-Imaging -- Part III. Clinical Trials -- 10. Review of Previous Clinical Trials and Guideline of Cell Therapy -- 11. Bone Marrow-Derived Mononuclear Cells -- 12. Mesenchymal Stem Cells.
• Publisher Details: Tokyo, Japan : Springer
• Publication Date: 2017
• Extent: 1 online resource (x, 156 pages), illustrations (some color)
• Subjects: 616.8/106; Cerebrovascular disease -- Chemotherapy; Cellular therapy; HEALTH & FITNESS -- Diseases -- General; MEDICAL -- Clinical Medicine; MEDICAL -- Diseases; MEDICAL -- Evidence-Based Medicine; MEDICAL -- Internal Medicine; Cellular therapy; Cerebrovascular disease -- Chemotherapy; Medicine & Public Health; Neurosurgery; Neurology; Regenerative Medicine/Tissue Engineering; Stroke -- drug therapy; Electronic books; Electronic book
• Languages: English
• ISBNs: 9784431560593; 4431560599; 4431560572; 9784431560579
• Related ISBNs: 9784431560579
• Notes: Note: Online resource; title from PDF title page (SpringerLink, viewed January 19, 2017).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.